Target intelligence / Profile preview

50S ribosomal subunit, 23S rRNA nascent peptide exit tunnel (NPET) (NPET)

Target
NPET
Molecular classification
Ribonucleoprotein, Ribosomal RNA, Bacterial ribosome subunit
01

Overview

The 50S ribosomal subunit's 23S rRNA nascent peptide exit tunnel (NPET) is a critical structural conduit within the bacterial ribosome that allows newly synthesized polypeptides to exit the peptidyl transferase center and reach the cellular environment (Wilson & Beckmann, 2011). Spanning approximately 80-100 Å in length, the tunnel is primarily composed of 23S ribosomal RNA and is shaped by ribosomal proteins such as uL4 and uL22 (Nissen et al., 2000). This site is the primary pharmacological target for several classes of clinically important antibiotics, most notably the macrolides, ketolides, and streptogramins (Patsnap Synapse, 2024). These drugs bind to specific nucleotides within the 23S rRNA, such as A2058 and A2059, to physically obstruct the passage of the growing peptide chain. This blockage results in the premature release of peptidyl-tRNA and the cessation of bacterial protein synthesis, making it a vital target for treating various bacterial infections. Beyond its role as a passive channel, the NPET also participates in translational regulation by interacting with specific nascent peptide sequences to induce ribosome stalling (Vazquez-Laslop & Mankin, 2018). Resistance to drugs targeting this site often arises through ribosomal mutations or enzymatic modifications, such as methylation by Erm-family methyltransferases (PubMed, 2017).

Other names
Ribosomal exit tunnelPolypeptide exit tunnel23S rRNA exit tunnel50S exit tunnelNascent peptide exit tunnel
02

Mechanism of action

Antibiotics bind to the 23S rRNA within the 50S ribosomal subunit to sterically block the nascent peptide exit tunnel, which prevents the elongation of the polypeptide chain and leads to the premature dissociation of peptidyl-tRNA from the ribosome.

03

Biological functions

Protein synthesisTranslation elongationPolypeptide transportTranslational regulation
04

Disease associations

Infection
05

Safety considerations

Antibiotic resistanceQT interval prolongationCYP3A4-mediated drug-drug interactionsGastrointestinal motility stimulationMitochondrial protein synthesis inhibition
06

Interacting drugs

Erythromycin

7 more in the full profile.

07

Biomarkers

23S rRNA A2058 mutation23S rRNA A2059 mutationErm methyltransferase expressionCfr methyltransferase expression

Beyond the preview

Go deeper on 50S ribosomal subunit, 23S rRNA nascent peptide exit tunnel (NPET) (NPET).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 50S ribosomal subunit, 23S rRNA nascent peptide exit tunnel (NPET) (NPET).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call